Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease [Phase 3]
Phase 3 clinical trial update evaluating radiation therapy and chemotherapy in Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment [Phase 2]
Phase 2 trial update of combination chemotherapy in Hodgkin's disease or non-Hodgkin lymphoma not responding to prior treatment.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: HD17 for Intermediate Stage Hodgkin Lymphoma [Phase 3]
A Phase 3 clinical trial update for HD17 in intermediate stage Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: JAK-inhibition in Recurrent Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating JAK inhibition in recurrent classical Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma [Phase 3]
Phase 3 clinical trial evaluating combination chemotherapy in treating young patients with Hodgkin's lymphoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating combination chemotherapy and radiation therapy in young Hodgkin's lymphoma patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy in young male patients with Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating everolimus and lenalidomide in relapsed or refractory non-Hodgkin or Hodgkin lymphoma; results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS) [Phase 1]
Phase 1 trial update for avelumab in previously treated advanced classical Hodgkin's lymphoma (JAVELIN HODGKINS) has terminated with results…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating brentuximab vedotin with combination chemotherapy in older adults with previously untreated stage II-IV Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma [Phase 2]
Phase 2 trial update evaluating combination chemotherapy with or without radiation therapy in favorable-risk Hodgkin Lymphoma among young pa…
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Treatment With Nivolumab at the Fixed Dose 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkins Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating fixed-dose nivolumab (40 mg) in relapsed/refractory Hodgkin lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Camrelizumab(SHR-1210) Combined With GEMOX in Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial investigating camrelizumab (SHR-1210) plus GEMOX in relapsed or refractory Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT [Phase 1]
Phase 1 trial exploring a calcineurin inhibitor-free graft-versus-host disease prevention regimen after related haploidentical peripheral bl…
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating total-body irradiation and fludarabine phosphate followed by donor peripheral blood stem cell transpla…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease [Phase 2]
Phase 2 trial of high-dose gemcitabine, busulfan, and melphalan for patients with refractory Hodgkin's lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 2]
Phase 2 trial investigating sirolimus, cyclosporine, and mycophenolate mofetil to prevent graft-versus-host disease in patients with blood c…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 clinical trial assessing donor atorvastatin to prevent severe acute GVHD after nonmyeloablative peripheral blood stem cell transplan…
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy [Phase 2]
A Phase 2 clinical trial update for OPTmizing Advanced Stage Hodgkin Lymphoma Therapy is listed, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial of atezolizumab in relapsed or refractory Hodgkin lymphoma was terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating Everolimus in combination with DHAP for relapsed or refractory Hodgkin Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase 2 multi-center trial of entinostat (SNDX-275) in relapsed or refractory Hodgkin's lymphoma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial investigating lenalidomide and temsirolimus in relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma across Phase …
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating bone marrow transplantation from fully matched relatives as donors for hematologic malignancies has completed; resu…
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update on donor umbilical cord blood transplant for hematologic cancers; status completed with results posted.